Article Summary
闫泽兆天欣邢影陈丹何璐璐.替吉奥联合顺铂治疗晚期胃癌临床疗效研究[J].现代生物医学进展英文版,2012,12(27):5324-5326.
替吉奥联合顺铂治疗晚期胃癌临床疗效研究
Curative Effect Analysis of S-1 Combined with Cisplatin in the Treatment ofAdvanced Gastric Cancer
  
DOI:
中文关键词: 胃肿瘤  替吉奥  卡培他滨  顺铂  治疗结果
英文关键词: Stomach neoplasms  S-1  Capecitabine  Cisplatin  Treatment outcome
基金项目:
Author NameAffiliation
YAN Ze, ZHAO Tian-xin, XING Ying, CHEN Dan, HE Lu-lu YAN Ze, ZHAO Tian-xin, XING Ying, CHEN Dan, HE Lu-lu 
Hits: 972
Download times: 931
中文摘要:
      目的:研究替吉奥联合顺铂治疗晚期胃癌的疗效和安全性。方法:42 例晚期胃腺癌患者随机分为观察组(21 例)与对照组(21 例)两组,观察组采用替吉奥联合顺铂,对照组采用卡培他滨联合顺铂。结果:两组患者疗效间差异无统计学意义(P>0.05)。两组的 不良反应主要为骨髓抑制、消化道反应和乏力,观察组Ⅲ~Ⅳ度血小板减少发生率显著低于对照组(P<0.05),Ⅲ ~ Ⅳ度手足综合 征的发生率亦显著低于对照组(P<0.05)。结论:替吉奥联合顺铂治疗晚期胃癌疗效与卡培他滨联合顺铂相当,但其患者耐受性更 好,值得临床进一步研究推广使用。
英文摘要:
      Objective: To investigate the safety and efficacy of S-1 combined with cisplatin in the treatment for patients with advanced gastric cancer. Methods: Forty-two patients with advanced gastric cancer were randomly divided into two groups. Patients in observation group (n=21) received S-1 and cisplatin; Patients in control group (n=21) received capecitabine and cisplatin. Results: The efficacy of the two groups showed no statistically significant difference (P>0.05). The main untoward effects were myelosuppression, gastroenteric reaction and weakness. Observation group showed a lower rate of untoward effects than control group. Observation group also showed a lower rate of Ⅲ~Ⅳ thrombocytopenia (P<0.05) and hand-foot syndrome (P<0.05) than control group. Conclusions: The treatment of the two groups were evidently effective, with observation group having better tolerance. The regimen could be clinically recommended.
View Full Text   View/Add Comment  Download reader
Close